|
Arunkumar, A. I., Srisailam, S., Krishnaswamy, T., Kumar, S., Kathir, K. M., Chi, Y. H., Wang, H. M., Chang, G. G., Chiu, I. M., Yu, C. “Structure and stability of an acidic fibroblast growth factor from notophthalmus viridescens” J. Bio. Chem., 2002, 277, 46424-46432.
Barber, A. J., Kaser-Glanzmann, R., Jakabova, M., & Luscher, E. F. “Characterization of a chondroitin 4-sulfate proteoglucan carrier from heparin neutralizing activity (platelet factor 4) released from human blood platelet” Biochim. Biophys. Acta., 1972, 286, 312-329.
Basilico, C., Mo scatelli, D. “The FGF family of growth factors and oncogenes” Adv. Cancer Res., 1992, 59, 115-165.
Bikfalvi, A., Klein, S., Pintucci, G., Rifkin, D. B. “Biological roles of fibroblast growth factor-2” Endocr. Rev., 1997, 18, 26-45.
Bohlen, P., Esch, F., Baird, A., Gospodarowicz, D. “Acidic fibroblast growth-factor (FGF) from bovine brain — amino-terminal sequence and comparison with basic FGF” EMBO J., 1985, 4, 1951-1956.
Brindley, L. L., Sweet, J. M., & Goetzl, E. J. “Stimulation of histamine-release from human basophils by human-platelet factor 4” J. Clin. Invest., 1983, 72, 1218-1223.
Brown, K. J., Rarish, C. R. “Histidine-rich glycoprotein and platelet factor-4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor” Biochemistry, 1994, 33, 13918-13927.
Burgess, W. H. and Maciag, T. “The heparin-binding (fibroblast) growth factor family of proteins” Annu. Rev. Biochem., 1989, 58, 575-606.
Busch, C., & Owen, W. G. “Identification invitro of an endothelial cell surface cofactor for antithrombin-III-parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium” J. Clin. Invest., 1982, 69, 726-729.
Dabora, J. M., Sanyal, G., Middaugh, C. R. “Effect of polyanions on the refolding of human acidic fibroblast growth factor” J. Bio. Chem., 1991, 266, 23637-23640.
Dameron, K. M., Volpert, O. V., Tainsky, M. A., Bouch, N. “Control of antiogenesis in fibroblasts by p53 regulation of thrombospondin-1” Science, 1994, 265, 1582-1584.
Davidson, J. M., Klagsbrun, M., Hill, K. E., Buckley, A., Sullivan, R. “Accelerated wound repair, cell proliferation, and collagen accumulation are produced by a cartilage-derived growth factor” J. Cell Biol., 1985, 100, 1219-1227.
Deuel, T. F., Kein, P. S., Farmer, M., & Heinrikson, R. L. “Amino acid sequence of human platelet factor 4” Proc. Natl. Acad. Sci. U.S. A., 1977, 74, 2256-2258.
Deuel, T. F., Senior, R. M., Chuang, D., Griffin, G. L., & & Heinrikson, R. L. “Platelet factor-4 is chemotactic for neutrophils and monocytes” Proc. Natl. Acad. Sci. U.S. A., 1981, 78, 4584-4587.
Esch, F., Ueno, Baird, A., Hill, F., Denoroy, L. “Primary structure of bovine brain acidic fibroblast growth-factor (FGF)” Biochem. Biophys. Res. Commun., 1985, 133, 554-562.
Ferrara, N., Davis-Smyth T. The biology of vascular endothelial growth factor” Endocr. Rev., 1997, 18, 4-25.
Gautschisova, P., Muller, T., Bohlen, P. “Amino-acid sequence of human acidic fibroblast growth-f actor” Biochem. Biophys. Res. Commun., 1986, 140, 874-880.
Gimenez-Gallego, G., Conn, G., Hatcher, V. B., Thomas, K. A. “Human brain-derived acidic and basic fibroblast growth-factors amino terminal sequences and specific mitogenic activities” Biochem. Biophys. Res. Commun., 1986, 135, 541-548.
Gospodarowicz, D. “Growth-factors and their action invivo and invitro” J. Pathol., 1983, 14, 201-223.
Gospodarowicz, D., Greenburg, G., Bialecki, H., Zetter, B. “Factors involved in the modulation of cell proliferation in vivo and in vitro: the role of fibroblast and epidermal growth factors in the proliferative response of mammalian cells” In Vitro, 1978, 14, 85-118.
Hagedorn, M., Zillberberg, L., Lozano, R. M., Cuevas, P., Canron, X., Redondo-Horcajo, M., Gimenez-Gallego, G., & Bikfalvi, A. “A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2” FASEB J., 2001, 15, 550-552.
Hajduk, P. J., Gerfin, T., Boehlen, J. M., Haberli, M., Marek, D. Fesik, S. W. “High-throughput nuclear magnetic resonance-based screening” J. Med. Chem., 1999, 42, 2315-2317.
Hansell, P., Maione, T. E., & Borgstrom, P. “Selective binding of platelet factor-4 to regions of active angiogenesis in vivo” Am. J. Physiol., 1995, 269, 829-836.
Harper, J. W., Strydom, D. J., Lobb, R. R. “Human class-1 heparin-binding growth-factor-structure and homology to bovine acidic brain fibroblast growth-factor” Biochemistry, 1986, 25, 4097-4103.
Hermodson, M., Schmer, G., & Kurachi, K. “Isolation, crystallization, and primary amino acid sequence of human platelet factor 4” J. Biol. Chem., 1977, 252, 6276-6279.
Hoffman, R. S., Growth, 1940, 4, 361-376.
Holt, J. C., Haris, M. E., Holt, A., Lange, E., Henschen, A., Niewiarowski, S. “Characterization of human-platelet basic protein, A precursor form of low-affinity platelet factor-IV and beta-thromboglobulin” Biochemistry, 1986, 25, 88-1996.
Johnson, D. E., Williams, L. T. “Structural and functional diversity in the FGF receptor multigen family” Adv. Cancer Res., 1993, 60, 1-41.
Jouan, V., Canron, X., Alemany, M., Caen, J. P., Quentin, G., Plouet, J., & Bikfalvi, A. “Inhibition of in vitro angiogenesis by platelet factor-4 derived peptides and mechanism of action” Blood, 1999, 94, 984-993.
Katoh, Y., Kodama, K., Ishikawa, T. “In vivo effects of epidermal and fibroblast growth factors on DNA replication in mouse skin” Esp. Cell Res., 1985, 161, 111-116.
Katz, I. R., Thorbecke, G. J., Bell, M. K., Yim, J. Z., Clarke, D., & Zucker, M. B. “Protease-induced immunoregulatory activity of platelet factor-IV” Proc. Natl. Acad. Sci. U.S. A., 1986, 783, 3491-3495.
Kolber, D. L., Knisely, T. L., & Maione, T. E. “Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor-4” J. Natl. Cancer Inst., 1995, 87, 304-309.
Lemmon, S. K., Riley, M. C. Thomas, K. A., Hoover, G. A., Maciag, T. Bradshaw, R. A. “Bovine fibroblast growth-factor comparison of brain and pituitary preparations” J. Cell Biochem., 1982, 95, 162-169.
Lobb, R. R., Harper, J. W., Fett, J. W. “Purification of heparin-binding growth-factors” Anal. Biochem., 1986, 154, 1-14.
Lobb, R. R. “Thrombin inactivates acidic fibroblast growth-factor but not fibroblast growth-factor” Biochemistry, 1988, 27, 2572-2578.
Lozano, R. M., Redondo-Horcajo, M., Jimenez, M. A., Zilberberg, L., Cuevas, P., Bikfalvi, A., Rico, M., & Gimenez-Gallego, G., “Solution structure and interaction with basic and acidic fibroblast growth factor of a 3-kDa human platelet factor-4 fragment with antiangiogenic activity” J. Biol. Chem., 2001, 276, 35723-35734.
Maciag, T., Cerundolo, J., Isley, S., Kelley, P. R, Forand, R. “An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization” Proc. Natl. Acad. Sci. U. S. A., 1979, 76, 5674-5678.
Maciag, T., Hoover, G. A., Stemerman, M. B., Weinstein, R. “Serial propagation of human endothelial cells in vitro” J. Cell. Biol., 1981, 91, 420-426.
Maciag, T., Mehlman, T., Friesel, R., Schreiber, A. B. “Heparin binds endothelial cell-growth factor, the principal endothelial-cell mitogen in bovine brain” Science, 1984, 225, 932-935.
Maione, T. E., Gray, G. S., Hunt, A. J., Sharpe, R. J. “Inhibition of tumor growth in mice by an analogue of platelet factor-4 that lacks affinity for heparin and retains potent angiostatic activity” Cancer Res., 1991, 51, 2077-2083.
Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., Sharpe, R. J. “Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides” Science, 1990, 247, 77-79.
Mayo, K. H., Ilyina, E., Roongta, V., Dundas, M., Joseph, J., Lai, C. K., Maione, T. E., Daly, T. J. “Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: Arginine residues are crucial for binding” Biochem. J., 1995, 312, 357-365.
Mayo, K. H., Chen, M. J. “Human-platelet factor-4 monomer dimmer tetramer equilibria investigated by H-1-NMR spectroscopy” Biochemistry, 1989, 28, 9469-9478.
Mayo, K. H., Roongta, V. Ilyina, E., Milius, R., Barker, S., Quinlan, C., Larosa, G., Daly, T. J. “NMR solution structure of the 32-kDa platelet factor-4 ELR-motif N-terminal chimera — a symmetrical tetramer” Biochemistry, 1995, 34, 11399-11409.
Ogura, K., Nagata, K., Hatanaka, H., Habuchi, H., Kimata, K., Tate, S., Ravera, M. W., Jaye, M. “Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide” J. Biomolec. NMR, 1999, 13, 11-24.
O’Reilly, M. S., Boehm, T., Shing, Y, Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., Folkman, J. “Endostatin: An endogenous inhibitor of angiogenesis and tumor growth” Cell, 1997, 88, 277-285.
O’Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., Folkman, J. “Angiostatin — A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung-carcinoma” Cell, 1994, 79, 315-328.
Perollet, C., Han, Z. C., Savona, C., Caen, J. P., & Bikfalvi, A. “Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization” Blood, 1998, 91, 3289-3299.
Pineda-Lucena, A., Jimenez, M. A., Lozano, R. M., Nieto, J. L., Santoro, J., Rico, M., Gimenez-Galego, G. “Three-dimensional structure of acidic fibroblast growth factor in solution: effects of binding to heparin functional analog” J. Mol. Biol., 1996, 264, 162-178.
Plotnikov, A. N., Schlessinger, J., Hubbard, S. R., Mohammadi, M. “structural basis for FGF receptor dimerization and activation” Cell, 1999, 98, 641-650.
Rosengart, T. K., Johnson, W., Friesel, R., Clark, R., Maciage, T. “Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro” Biochem, Biophys, Res. Commun., 1988, 152, 432-440.
Schlessinger, J., Ullrichrich, A. “Growth factor signaling by receptor tyrosin kinases” Neuron, 1992, 9, 383-391.
Sharpe, R. J., Byers, H. R., Scott, C. F., Bauer, S. Y., & Maione, T. E. “Growth-inhibition of murine melanoma and human colon-carcinoma by recombinant human platelet factor-IV” J. Natl. Cancer Inst., 1990, 82, 848-853.
Shing, Y., Folkman, J., Murray, M., Klagsbrun, M. “Purification by affinity-chromatography on heparin-sepharose of a growth-factor that stimulates capillary endothelial cell-proliferation” J. Cell Biol., 1983, 97, 395.
Senior, R. M., Huang, S. S., Griffin, G. L., Huang, J. S. “Brain-derived growth factor is a chemoattractant for fibroblasts and astroglial cells” Biochem. Biophys. Res. Commun., 1986, 141, 67-72.
Sommer, A., Rifkin, D. B. “Interaction of heparin with human basic fibroblast growth-factor-protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan” J. Cell Physiol., 1989, 138, 215-220.
St. Charles, R., Walz, D. A., Edwards, B. F. P. “The 3-dimensional structure of bovine platelet factor-4 at 3.0-A resolution” J. Biol Chem., 1989, 264, 2092-2099.
Strydom, D. J., Harper, J. W., Lobb, R. R. “Amino-acid sequence of bovine brain derived class-1 heparin-binding growth-factor” Biochemistry, 1986, 25, 945-951.
Tanaka, T., Manome, T., Wen, P., Kufe, D. W., & Fine, H. A. “Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth” Nat. Med., 1997, 3, 437-442.
Terranova, V. P., Diflorio, R., Lyall, R. M., Hic, S., Friesel, R., Maciag, T. “Human endothelial cells are chemotactic to endothelial cell growth factor and heparin” J. Cell Biol., 1985, 101, 2330-2334.
Thomas, K. A., Riley, M. C., Lemmon, S. K., Bagian, N. C., Bradshaw, R. A. “Brain fibroblast growth-factor-nonindentity with myelin basic-protein fragments” J. Biol. Chem., 1980, 255, 5517-5520.
Thornto, S. C., Mueler, S. N., Levine, E. M. “Human-endothelial cells-use of heparin in cloning and long-term serial cultivation” Science, 1983, 222, 623-625.
Trowell, O. A., Chir, B., Willmer, E. N. “Studies of the growth of tissues in vitro” J. Exp. Biol., 1939, 16, 60-70.
Van der Geer, P., Hunter, T., Lindberg, R. A. “Receptor protein-tyrosine kinases and their signal transduction pathways” Annu. Rev. Cell Biol., 1994, 10, 251-337.
Zhang, X. H., Chen, L. Q., Bancroft, D. P., Lai, C. K., Maione, T. E. “Crystal-structure of recombinant human platelet factor-4” Biochemistry, 1994, 33, 8361-8366.
Zhu, X., Komiya, H., Chirino, A., Faham, S., Fox, G. M., Arakawa, T., Hus, B. T., Rees, D. D. “3-Dimensional structures of acidic and basic fibroblast growth factors” Science, 1991, 251, 90-93.
謝惠珠, “當今液態核磁共振儀在蛋白質分子之重要發展及應用”, 科儀新知, 2001, 121, 45-57.
|